We’d love to hear your feedback on this activity. It helps us to continually improve our products.
New journal coming to touchIMMUNOLOGY soon!
touchREVIEWS in RMD. 2024;3(2):Online ahead of journal publication
International experts from the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) have recently partnered to produce the much-anticipated classification criteria for antiphospholipid syndrome (APS), which were published in Arthritis & Rheumatology in August 2023.1 Prior to the publication of the new ACR/EULAR APS classification criteria, research studies used the Sapporo criteria, […]
Chronic back pain (CBP), defined as back pain lasting for 3 months or more, is the most common pain condition globally.1 Greater healthcare utilization, productivity limitations and poor quality of life have immediate and long-term impacts on patients and the healthcare system.2 The guidelines recommend physiotherapy as a frontline intervention, alongside education and behavioural interventions.3 […]
Welcome to the latest edition of touchREVIEWS in RMD! We’re excited to share a dynamic collection of articles that highlight the evolving landscape of rheumatic and musculoskeletal diseases (RMDs). We open the issue by delving into a series of editorials offering expert insights and critical analyses on recent developments and key issues in the field. […]
Get the latest clinical insights from touchIMMUNOLOGY